Keynote speakers

Elizabeth M. Swisher, M.D. is a professor in gynecologic oncology and adjunct professor in medical genetics and is the director of the Breast and Ovarian Cancer Prevention Program at the Seattle Cancer Care Alliance. She has a research and clinical focus on the genetics and prevention of gynecologic cancers.
Dr. Swisher earned a B.S. from Yale University and received her M.D. from the University of California at San Diego. She completed her residency at the University of Washington in Ob/Gyn and a fellowship in gynecologic oncology at Washington University St Louis. She is board certified in gynecologic oncology and obstetrics and gynecology.

Dr. Swisher's clinical interests include gynecologic cancer, cancer prevention, cancer genetics, novel therapeutics and minimal invasive surgery.

Five recent publications:

Iain McNeish is Professor of Oncology and Head of the Division of Cancer within the Department of Surgery and Cancer, at Imperial College London. He is also the Director of the Ovarian Cancer Action Research Centre and Cancer theme lead in the Imperial NIHR Biomedical Research Centre (BRC). Externally, he is Chair of the National Cancer Research Institute (NCRI) Gynaecological Clinical Study Group.

His research focuses on ovarian cancer, specifically developing improved therapies through improved understanding of disease biology. With James Brenton in Cambridge, he co-leads the BriTROC translational research collaborative and holds a programme grant from Cancer Research UK investigating copy number alterations in ovarian high grade serous carcinoma (HGSC) as a possible prognostic and predictive biomarker. His group has also recently developed novel transplantable murine models of HGSC using CRISPR/Cas9 gene editing technology to allow investigation of novel therapies in an immunocompetent model. These transplantable cells are freely available to researchers.

Five recent publications: